Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$8.949M
TTM
Current Assets
$2.430M
Q4 2018
Current Liabilities
$4.483M
Q4 2018
Current Ratio
54.2%
Q4 2018
Total Assets
$4.560M
Q4 2018
Total Liabilities
$4.375M
Q4 2018
Book Value
$185.0K
Q4 2018
Cash
$1.485M
Q4 2018
P/E
-0.08217
Sep 13, 2024 EST
Free Cash Flow
-$7.115M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue $2.879M $1.347M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.030M $1.650M $690.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 113.73% -100.0% -37.58% 139.13%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue $2.879M $1.347M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.030M $1.650M $690.0K $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $683.0K $322.0K
Gross Profit $2.196M $1.025M
Gross Profit Margin 76.28% 76.1%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Selling, General & Admin $6.328M $6.509M $3.778M $1.902M $2.469M $4.371M $3.810M $1.268M $1.360M $1.420M $1.069M $1.292M $1.340M $1.080M $1.070M $1.540M $2.510M $460.0K $140.0K $20.00K
YoY Change -2.78% 72.29% 98.63% -22.96% -43.51% 14.72% 200.47% -6.76% -4.23% 32.81% -17.24% -3.59% 24.07% 0.93% -30.52% -38.65% 445.65% 228.57% 600.0%
% of Gross Profit 288.16% 635.02%
Research & Development $1.641M $2.803M $1.990M $649.0K $1.639M $2.710M $1.943M $740.0K $240.0K $480.0K $1.250M $2.180M $3.480M $3.640M $1.910M $2.870M $2.550M $1.210M $620.0K $70.00K
YoY Change -41.46% 40.85% 206.63% -60.4% -39.52% 39.48% 162.57% 208.33% -50.0% -61.6% -42.66% -37.36% -4.4% 90.58% -33.45% 12.55% 110.74% 95.16% 785.71%
% of Gross Profit 74.73% 273.46%
Depreciation & Amortization $538.0K $187.0K $33.00K $164.0K $179.0K $147.0K $5.000K $4.000K $0.00 $40.00K $46.85K $78.54K $210.0K $200.0K $140.0K $70.00K $50.00K $20.00K $0.00 $0.00
YoY Change 187.7% 466.67% -79.88% -8.38% 21.77% 2840.0% 25.0% -100.0% -14.61% -40.35% -62.6% 5.0% 42.86% 100.0% 40.0% 150.0%
% of Gross Profit 24.5% 18.24%
Operating Expenses $9.011M $9.312M $5.768M $2.551M $4.108M $7.081M $5.753M $2.034M $2.550M $1.940M $364.3K $3.461M $3.350M $4.720M $2.980M $4.410M $5.050M $1.670M $760.0K $90.00K
YoY Change -3.23% 61.44% 126.11% -37.9% -41.99% 23.08% 182.84% -20.24% 31.44% 432.53% -89.47% 3.31% -29.03% 58.39% -32.43% -12.67% 202.4% 119.74% 744.44%
Operating Profit -$6.815M -$8.287M -$5.768M -$2.551M
YoY Change -17.76% 43.67% 126.11%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Interest Expense $954.0K $6.913M -$15.00K $593.0K -$263.0K $685.0K -$490.0K $0.00 -$40.00K $10.00K -$11.85K -$1.929K $80.00K -$30.00K $180.0K $770.0K $170.0K -$50.00K -$20.00K
YoY Change -86.2% -46186.67% -102.53% -325.48% -138.39% -239.8% -100.0% -500.0% -184.4% 514.26% -102.41% -366.67% -116.67% -76.62% 352.94% -440.0% 150.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.204M -$6.000K -$835.0K -$108.0K $22.00K -$7.000K -$10.00K -$110.0K $433.7K -$58.42K -$1.470M -$450.0K -$460.0K $0.00 $0.00
YoY Change -100.0% 19966.67% -99.28% 673.15% -590.91% -30.0% -90.91% -125.36% -842.45% -96.03% 226.67% -2.17%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Pretax Income -$5.861M -$2.578M -$5.789M -$3.535M -$4.479M -$6.534M -$6.244M -$2.007M -$2.620M -$2.010M $57.59K -$3.649M -$3.720M -$3.550M -$2.570M -$3.640M -$4.890M -$1.720M -$780.0K -$90.00K
YoY Change 127.35% -55.47% 63.76% -21.08% -31.45% 4.64% 211.11% -23.4% 30.35% -3590.01% -101.58% -1.9% 4.79% 38.13% -29.4% -25.56% 184.3% 120.51% 766.67%
Income Tax $22.00K $14.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$5.122M -$2.592M -$5.789M -$3.482M -$4.794M -$8.949M -$6.244M -$1.993M -$2.540M -$1.990M $57.04K -$3.649M -$3.720M -$3.550M -$2.570M -$3.640M -$4.890M -$1.720M -$780.0K -$90.00K
YoY Change 97.61% -55.23% 66.26% -27.37% -46.43% 43.32% 213.3% -21.54% 27.64% -3588.66% -101.56% -1.9% 4.79% 38.13% -29.4% -25.56% 184.3% 120.51% 766.67%
Net Earnings / Revenue -177.91% -192.43% -361.17% -215.15% -372.46%
Basic Earnings Per Share
Diluted Earnings Per Share -$14.43 -$0.57 -$2.830M -$100.0K -$32.00K -$60.00K -$53.49K -$53.21K -$106.5K -$123.8K $5.605K -$857.5K -$0.93 -$1.05 -$0.81 -$1.18 -$1.77 -$0.64 -$0.78 -$0.10

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Cash & Short-Term Investments $5.076M $3.574M $6.875M $1.946M $870.0K $1.485M $9.195M $676.0K $1.690M $170.0K $1.411M $792.3K $3.300M $5.600M $6.270M $6.250M $6.970M $6.770M $8.010M $100.0K
YoY Change 42.03% -48.01% 253.29% 123.68% -41.41% -83.85% 1260.21% -60.0% 894.12% -87.96% 78.16% -75.99% -41.07% -10.69% 0.32% -10.33% 2.95% -15.48% 7910.0%
Cash & Equivalents $1.485M $9.195M $676.0K $1.690M $170.0K $1.411M $792.3K $3.300M $5.600M $6.270M $3.930M $2.540M $1.680M $3.590M $100.0K
Short-Term Investments $3.000M $0.00 $2.320M $4.420M $5.080M $4.410M $0.00
Other Short-Term Assets $268.0K $100.0K $393.0K $318.0K $21.00K $260.0K $24.00K $11.00K $10.00K $10.00K $90.11K $2.100M $4.310M $4.000M $3.480M $0.00
YoY Change 168.0% -74.55% 23.58% 1414.29% -91.92% 983.33% 118.18% 10.0% 0.0% -88.9% 7.75% 14.94%
Inventory $742.0K $668.0K
Prepaid Expenses
Receivables $22.00K $77.00K $278.0K $117.0K $80.00K $30.00K $33.62K $195.9K $460.0K $350.0K $160.0K $110.0K $390.0K $270.0K $130.0K $0.00
Other Receivables $337.0K $91.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $6.445M $4.510M $9.824M $2.550M $955.0K $2.430M $9.497M $804.0K $1.780M $210.0K $1.535M $988.2K $3.760M $5.950M $8.530M $6.370M $11.67M $11.04M $11.62M $110.0K
YoY Change 42.9% -54.09% 285.25% 167.02% -60.7% -74.41% 1081.22% -54.83% 747.62% -86.32% 55.35% -73.72% -36.81% -30.25% 33.91% -45.42% 5.71% -4.99% 10463.64%
Property, Plant & Equipment $108.0K $57.00K $92.00K $11.00K $175.0K $2.107M $50.00K $11.00K $10.00K $20.00K $87.63K $134.8K $180.0K $210.0K $290.0K $310.0K $310.0K $190.0K $10.00K $0.00
YoY Change 89.47% -38.04% 736.36% -93.71% -91.69% 4114.0% 354.55% 10.0% -50.0% -77.18% -34.97% -25.14% -14.29% -27.59% -6.45% 0.0% 63.16% 1800.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.440M $1.321M $0.00 $50.00K $0.00 $290.0K $3.220M
YoY Change 9.01% -100.0% -100.0% -90.99%
Other Assets $0.00 $24.00K $23.00K $19.00K $430.0K $0.00 $3.050M $280.0K
YoY Change -100.0% 4.35% 21.05% -95.58% -100.0%
Total Long-Term Assets $4.737M $6.095M $92.00K $11.00K $199.0K $2.130M $69.00K $441.0K $10.00K $70.00K $87.63K $134.8K $310.0K $4.090M $3.700M $3.640M $3.530M $190.0K $280.0K $0.00
YoY Change -22.28% 6525.0% 736.36% -94.47% -90.66% 2986.96% -84.35% 4310.0% -85.71% -20.12% -34.97% -56.53% -92.42% 10.54% 1.65% 3.12% 1757.89% -32.14%
Total Assets $11.18M $10.61M $9.916M $2.561M $1.154M $4.560M $9.566M $1.245M $1.790M $280.0K $1.623M $1.123M $4.070M $10.04M $12.23M $10.01M $15.20M $11.23M $11.90M $110.0K
YoY Change
Accounts Payable $264.0K $298.0K $441.0K $277.0K $339.0K $1.618M $1.017M $590.0K $490.0K $330.0K $428.8K $597.4K $730.0K $540.0K $420.0K $440.0K $210.0K $180.0K $250.0K $20.00K
YoY Change -11.41% -32.43% 59.21% -18.29% -79.05% 59.1% 72.37% 20.41% 48.48% -23.04% -28.23% -18.16% 35.19% 28.57% -4.55% 109.52% 16.67% -28.0% 1150.0%
Accrued Expenses $690.0K $1.080M $841.0K $313.0K $633.0K $536.0K
YoY Change -36.11% 28.42% 168.69% -50.55% 18.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $188.0K $67.00K $1.147M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 180.6% -94.16%
Long-Term Debt Due $52.00K $27.00K $45.00K $0.00 $1.420M $3.870M $30.00K
YoY Change 92.59% -40.0% -100.0%
Total Short-Term Liabilities $1.571M $4.156M $1.757M $1.131M $1.046M $4.483M $1.177M $672.0K $550.0K $360.0K $632.4K $717.0K $940.0K $920.0K $3.430M $990.0K $4.930M $480.0K $480.0K $90.00K
YoY Change -62.2% 136.54% 55.35% 8.13% -76.67% 280.88% 75.15% 22.18% 52.78% -43.08% -11.8% -23.72% 2.17% -73.18% 246.46% -79.92% 927.08% 0.0% 433.33%
Long-Term Debt $24.00K $0.00 $18.00K $0.00 $94.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.420M $0.00 $3.740M $4.020M $0.00
YoY Change -100.0% -100.0% -100.0% -100.0% -6.97%
Other Long-Term Liabilities $0.00 $40.00K $35.27K $2.448M $2.260M $5.880M $5.020M $1.740M $1.640M $10.00K $0.00
YoY Change -100.0% 13.4% -98.56% 8.3% -61.56% 17.13% 188.51% 6.1% 16300.0%
Total Long-Term Liabilities $24.00K $0.00 $18.00K $0.00 $94.00K $0.00 $0.00 $0.00 $0.00 $40.00K $35.27K $2.448M $2.260M $5.880M $5.020M $3.160M $1.640M $3.750M $4.020M $0.00
YoY Change -100.0% -100.0% -100.0% 13.4% -98.56% 8.3% -61.56% 17.13% 58.86% 92.68% -56.27% -6.72%
Total Liabilities $3.568M $4.156M $1.775M $1.131M $1.140M $4.375M $1.177M $672.0K $380.0K $320.0K $605.7K $3.165M $3.200M $6.790M $8.450M $4.150M $6.570M $4.240M $4.500M $90.00K
YoY Change -14.15% 134.14% 56.94% -0.79% -73.94% 271.71% 75.15% 76.84% 18.75% -47.17% -80.86% -1.11% -52.87% -19.64% 103.61% -36.83% 54.95% -5.78% 4900.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $735.36 Thousand

About Scisparc Ltd

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Industry: Pharmaceutical Preparations Peers: Biomx Inc Galmed Pharmaceuticals Ltd Neurosense Therapeutics Ltd Notable Labs Ltd